Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting-Reference-Cited by-同舟云学术

Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting

Published:2017-09-18 Issue:15 Volume:77 Page:1478-1488
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Miyahira Andrea K.¹^ORCID,Cheng Heather H.²³,Abida Wassim⁴,Ellis Leigh⁵⁶,Harshman Lauren C.⁷^ORCID,Spratt Daniel E.⁸,Simons Jonathan W.¹,Pienta Kenneth J.⁹¹⁰¹¹,Soule Howard R.¹

Affiliation:

1. Prostate Cancer Foundation; Santa Monica California

2. Department of Medicine; University of Washington; Seattle Washington

3. Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle Washington

4. Genitourinary Oncology Service, Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York

5. Department of Oncologic Pathology; Dana-Farber Cancer Institute; Boston Massachusetts

6. Department of Pathology; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

7. Lank Center for Genitourinary Oncology; Dana-Farber Cancer Institute and Harvard Medical School; Boston Massachusetts

8. Department of Radiation Oncology; University of Michigan; Ann Arbor Michigan

9. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center; The Johns Hopkins School of Medicine; Baltimore Maryland

10. Department of Urology; The James Buchanan Brady Urological Institute; Baltimore Maryland

11. Department of Pharmacology and Molecular Sciences; The Johns Hopkins School of Medicine; Baltimore Maryland

Publisher

Wiley

Subject

Urology,Oncology

Reference102 articles.

1. Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting;Pienta;Prostate,2014

2. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting;Miyahira;Prostate,2015

3. Multidisciplinary intervention of early, lethal metastatic prostate cancer: report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting;Miyahira;Prostate,2016

4. Beyond seed and soil: understanding and targeting metastatic prostate cancer; report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting;Miyahira;Prostate,2017

5. Eleventh prouts neck meeting on prostate cancer: emerging strategies in prostate cancer therapy;Keller;Cancer Res,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting;The Prostate;2024-04-29

3. A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer;The Prostate;2024-02-20

4. Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting;The Prostate;2022-11-28

5. Prostate cancer research in the 21st century; report from the 2021 Coffey‐Holden prostate cancer academy meeting;The Prostate;2021-11-03